What is Zacks Small Cap’s Estimate for ORMP Q1 Earnings?
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Free Report) – Equities researchers at Zacks Small Cap issued their Q1 2025 earnings per share (EPS) estimates for shares of Oramed Pharmaceuticals in a research note issued on Thursday, April 3rd. Zacks Small Cap analyst M. Marin forecasts that the biotechnology company will post earnings per share of ($0.01) […]
